PRESENTATION

Q3 2020 — Presentation

Q3 2020PDF · 15 pages370 KB
Northrop Grumman Third Quarter
2020 Conference Call
Chairman, Chief Executive Officer
and President
Kathy Warden
October 22, 2020
1
Dave Keffer
Corporate Vice President and
Chief Financial Officer

-- 1 of 15 --

Forward-Looking Statements
This presentation and the information we are incorporating by reference, and statements to be made on the earnings conference call, contain or may contain statements that constitute
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “will,” “expect,” “anticipate,” “intend,” “may,” “could,” “should,”
“plan,” “project,” “forecast,” “believe,” “estimate,” “guidance,” “outlook,” “trends,” “goals” and similar expressions generally identify these forward-looking statements.
Forward-looking statements include, among other things, statements relating to our future financial condition, results of operations and/or cash flows. Forward-looking statements are
based upon assumptions, expectations, plans and projections that we believe to be reasonable when made, but which may change over time. These statements are not guarantees of
future performance and inherently involve a wide range of risks and uncertainties that are difficult to predict. Specific risks that could cause actual results to differ materially from those
expressed or implied in these forward-looking statements include, but are not limited to, those identified and discussed more fully in the section entitled “Risk Factors” in the Form 10-K for
the year ended December 31, 2019, the section entitled “Risk Factors” in the Form 10-Q for the quarter ended March 31, 2020 and from time to time in our other filings with the Securities
and Exchange Commission (SEC). These risks and uncertainties are amplified by the global COVID-19 pandemic, which has caused and will continue to cause significant challenges,
instability and uncertainty. They include:
– 	the impact of the COVID-19 outbreak or future epidemics on our business, including the potential for worker absenteeism, facility closures, work slowdowns or stoppages, supply
chain disruptions, program delays, our ability to recover costs under contracts, changing government funding and acquisition priorities and processes, changing government payment
rules and practices, and potential impacts on access to capital, the markets and the fair value of our assets
– 	our dependence on the U.S. government for a substantial portion of our business
– 	significant delays or reductions in appropriations for our programs, and U.S. government funding and program support more broadly
– 	investigations, claims, disputes, enforcement actions, litigation and/or other legal proceedings
– 	the use of estimates when accounting for our contracts and the effect of contract cost growth and/or changes in estimated contract revenues and costs
– 	our exposure to additional risks as a result of our international business, including risks related to geopolitical and economic factors, suppliers, laws and regulations
– 	the improper conduct of employees, agents, subcontractors, suppliers, business partners or joint ventures in which we participate and the impact on our reputation and our ability to do
business
– 	cyber and other security threats or disruptions faced by us, our customers or our suppliers and other partners
– 	the performance and financial viability of our subcontractors and suppliers and the availability and pricing of raw materials and components
– 	changes in procurement and other laws, regulations, contract terms and practices applicable to our industry, findings by the U.S. government as to our compliance with such
requirements, and changes in our customers’ business practices globally
– 	increased competition within our markets and bid protests
– 	the ability to maintain a qualified workforce with the required security clearances and requisite skills
– 	our ability to meet performance obligations under our contracts, including obligations that require innovative design capabilities, are technologically complex, require certain
manufacturing expertise or are dependent on factors not wholly within our control
– 	environmental matters, including unforeseen environmental costs and government and third party claims
– 	natural disasters
– 	health epidemics, pandemics and similar outbreaks, including the global COVID-19 pandemic
– 	the adequacy and availability of our insurance coverage, customer indemnifications or other liability protections
– 	products and services we provide related to hazardous and high risk operations, including the production and use of such products, which subject us to various environmental,
regulatory, financial, reputational and other risks
– 	the future investment performance of plan assets, changes in actuarial assumptions associated with our pension and other postretirement benefit plans and legislative or other
regulatory actions impacting our pension and postretirement benefit obligations
– 	our ability appropriately to exploit and/or protect intellectual property rights
– 	our ability to develop new products and technologies and maintain technologies, facilities, and equipment to win new competitions and meet the needs of our customers
– 	unanticipated changes in our tax provisions or exposure to additional tax liabilities
– 	changes in business conditions that could impact business investments and/or recorded goodwill or the value of other long-lived assets
You are urged to consider the limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of forward-looking statements. These forward-
looking statements speak only as of the date this presentation is first issued or, in the case of any document incorporated by reference, the date of that document. We undertake no
obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
This presentation and the attachments also contain non-GAAP financial measures. A reconciliation to the nearest GAAP measure and a discussion of the company’s use of these
measures are included in this presentation.
2

-- 2 of 15 --

• 	$20.3B Net Awards; backlog increases to record $81.3B
• 	Book to Bill 2.2x
• 	Sales increase 7% to $9.1B
• 	11.5% Segment OM%(1)
• 	EPS increase 7% to $5.89
• 	Cash flow from Operations increases 19% to $1.4B
• 	Free Cash Flow (1) 22% higher to $1.1B
• 	Sales, MTM-adjusted EPS(1) , and Free Cash Flow (1) guidance
increased for year-to-date performance
Q3 2020 Highlights
3
(1) Non-GAAP metric. See Appendix.

-- 3 of 15 --

Q3 2020 EPS Bridge
4
$5.49
$5.89
Q3 2019 	Q3 2020
EPS
EPS
Q3 2019 	$ 5.49
Segment Performance 	0.51
Corporate Unallocated 	(0.18)
Net Pension 	0.40
Net Interest 	(0.17)
Taxes and Other Items 	(0.16)
Q3 2020 	$5.89
+7%

-- 4 of 15 --

Three Months
Ended September 30
Nine Months
Ended September 30
Q3 2019 	Q3 2020 	▲% 	YTD 2019 YTD 2020 	▲%
Aeronautics Systems 	2,770 	2,914 	5% 	8,309 	8,682 	4%
Defense Systems 	1,931 	1,859 	(4%) 	5,615 	5,626 	-
Mission Systems 	2,310 	2,551 	10% 	6,924 	7,344 	6%
Space Systems 	1,885 	2,198 	17% 	5,474 	6,194 	13%
Intersegment Eliminations 	(421) 	(439) 	(1,202) 	(1,259)
Total Sales 	$ 	8,475 	$ 	9,083 	7% 	$ 25,120 $ 26,587 	6%
Sales
5
$8,475
$9,083
Q3 2019 	Q3 2020
Sales (millions)
+7%

-- 5 of 15 --

Segment Operating Income(1)
6
Three Months
Ended September 30
Nine Months
Ended September 30
Q3 2019 	Q3 2020 	▲ 	YTD 2019 YTD 2020 	▲
Aeronautics Systems 	9.7% 	10.1% 	40 bps 	10.6% 	10.0% (60) bps
Defense Systems 	10.4.% 	11.7% 	130 bps 	11.0% 	11.2% 	20 bps
Mission Systems 	15.2% 	14.5% 	(70) bps 	14.6% 	14.6% 	-
Space Systems 	10.1% 	10.2% 	10 bps 	10.5% 	10.3% (20) bps
Segment Operating Margin (1) 	11.3% 	11.5% 	20 bps 	11.6% 	11.5% 	(10) bps
$955
$1,049
Q3 2019 	Q3 2020
Segment Operating
Income (1) (millions)
+10%
(1) Non-GAAP metric. See Appendix.
Three Months
Ended September 30
Nine Months
Ended September 30
Q3 2019 	Q3 2020 	▲% YTD
2019
YTD
2020 ▲%
Aeronautics Systems 	269 	294 	9% 	879 	867 	(1%)
Defense Systems 	201 	217 	8% 	617 	632 	2%
Mission Systems 	351 	370 	5% 	1,012 	1,070 	6%
Space Systems 	191 	224 	17% 	574 	635 	11%
Intersegment Eliminations 	(57) 	(56) 	(156) 	(157)
Segment Operating Income(1) 	$ 	955 	$ 	1,049 	10% 	$ 	2,926 	$ 	3,047 	4%

-- 6 of 15 --

2020 Sector Guidance(1)
7
As of 7/30/2020(1) 	As of 10/22/2020(1)
Aeronautics Systems
Sales $B 	Low to Mid 11 	Mid 11
OM Rate 	~10% 	~10%
Defense Systems
Sales $B 	Mid 7 	Mid 7
OM Rate 	Mid 10% 	~11%
Mission Systems
Sales $B 	High 9 	High 9
OM Rate 	Low to Mid 14% 	Mid 14%
Space Systems
Sales $B 	Low 8 	Mid 8
OM Rate 	Low to Mid 10% 	Low 10%
(1) Financial guidance, as well as outlook, trends, expectations and other forward looking statements provided by the company for 2020, 2021 and beyond, reflect the company's judgment based on the
information available to the company at the time of this release. The company is increasing its 2020 financial guidance based on year-to-date performance and its most current outlook for the remainder of
the year. The company’s 2020 financial guidance and outlook for 2021 and beyond reflect the impacts experienced to date from the global COVID-19 pandemic (discussed in the company’s Form 10-Qs),
and what the company currently anticipates, based on what the company understands today, to be the impacts on the company for the remainder of the year and beyond. The company’s updated financial
guidance and outlook assume generally that the most significant adverse impacts from the pandemic on the company’s business, financial position, results of operations or cash flows occurred in the
second quarter of 2020. However, the company cannot predict how the pandemic will evolve or what impact it will continue to have, and there can be no assurance that the company’s underlying
assumptions are correct. As discussed more fully in the company’s Form 10-Qs (for Q1, Q2 and Q3), and among other factors, disruptions to the company’s operations (or those of its customers or supply
chain), additional costs, disruptions in the market, and impacts on programs or payments relating to the global COVID-19 pandemic, today and as it may evolve, can be expected to affect the company’s
ability to achieve guidance or meet expectations. In addition, the government budget, appropriations and procurement processes can impact our customers, programs and financial results. These
processes, including the timing of appropriations and the occurrence of an extended continuing resolution and/or prolonged government shutdown, as well as a breach of the debt ceiling, or changes in
support for our programs or in federal corporate tax rates, can impact the company's ability to achieve guidance or meet expectations.

-- 7 of 15 --

2020 Guidance(1)
8
(1) Financial guidance, as well as outlook, trends, expectations and other forward looking statements provided by the company for 2020, 2021 and beyond, reflect the company's judgment based on the information
available to the company at the time of this release. The company is increasing its 2020 financial guidance based on year-to-date performance and its most current outlook for the remainder of the year. The
company’s 2020 financial guidance and outlook for 2021 and beyond reflect the impacts experienced to date from the global COVID-19 pandemic (discussed in the company’s Form 10-Qs), and what the
company currently anticipates, based on what the company understands today, to be the impacts on the company for the remainder of the year and beyond. The company’s updated financial guidance and
outlook assume generally that the most significant adverse impacts from the pandemic on the company’s business, financial position, results of operations or cash flows occurred in the second quarter of 2020.
However, the company cannot predict how the pandemic will evolve or what impact it will continue to have, and there can be no assurance that the company’s underlying assumptions are correct. As discussed
more fully in the company’s Form 10-Qs (for Q1, Q2 and Q3), and among other factors, disruptions to the company’s operations (or those of its customers or supply chain), additional costs, disruptions in the
market, and impacts on programs or payments relating to the global COVID-19 pandemic, today and as it may evolve, can be expected to affect the company’s ability to achieve guidance or meet expectations.
In addition, the government budget, appropriations and procurement processes can impact our customers, programs and financial results. These processes, including the timing of appropriations and the
occurrence of an extended continuing resolution and/or prolonged government shutdown, as well as a breach of the debt ceiling, or changes in support for our programs or in federal corporate tax rates, can
impact the company's ability to achieve guidance or meet expectations.
(2) Non-GAAP metric. See Appendix.
(3) Effective April 1, 2020, certain unallowable costs previously included in segment operating results are now reported in Unallocated corporate expense within operating income.
(4) Total Net FAS/CAS pension adjustment is presented as a single amount consistent with our historical presentation, and includes $825 million of expected CAS pension cost and $800 million of expected FAS
pension benefit. $410 million of FAS (service-related) pension cost is reflected in operating income and $1,210 million of FAS (non-service) pension benefit is reflected below operating income. CAS pension
cost continues to be recorded in operating income.
2020 (millions, except per share amounts) 	As of 7/30/2020(1) 	As of 10/22/2020(1)
Sales 	35,300 – 35,600 	35,700 – 36,000
Segment operating margin % (2)(3) 	11.3 – 11.5% 	11.3 – 11.5%
Total Net FAS/CAS pension adjustment (4) 	~1,600 	~1,625
Unallocated corporate expense
Intangible asset amortization and PP&E step-up depreciation 	~315 	~315
Other items 	~250 	~250
Operating margin % 	10.8 – 11.0% 	10.8 – 11.0%
Interest expense 	~590 	~590
Effective tax rate % 	~16.5% 	~16.5%
Weighted average diluted shares outstanding 	~168 	~168
MTM-adjusted EPS (2) 	22.00 – 22.40 	22.25 – 22.65
Capital expenditures 	~1,350 	~1,350
Free cash flow(2) 	3,150 – 3,550 	3,300 – 3,600

-- 8 of 15 --

2020E MTM-adjusted EPS(1) Bridge
9
(1)
(1)
(1) Non-GAAP metric. See Appendix.
EPS
2020 EPS Guidance as of 7/30/2020 (1) 	$22.00 - $22.40
Segment Operations 	~.25
2020 EPS Guidance as of 10/22/2020 (1) 	$22.25 - $22.65

-- 9 of 15 --

2021 Outlook - 10/22/2020(1)
• 	Expect 2021 sales in the low to mid $37 billion range
• 	Expect 2021 Segment OM(2) rate near lower end of 2020 guidance of
11.3% to 11.5%
• 	Continued strong free cash flow (2)
• 	Net FAS/CAS pension adjustment likely $150 - $250 million lower than
1/30/20 estimate due to potential changes in pension assumptions
10
(1) Financial guidance, as well as outlook, trends, expectations and other forward looking statements provided by the company for 2020, 2021 and beyond, reflect the company's judgment based on the
information available to the company at the time of this release. The company is increasing its 2020 financial guidance based on year-to-date performance and its most current outlook for the remainder of
the year. The company’s 2020 financial guidance and outlook for 2021 and beyond reflect the impacts experienced to date from the global COVID-19 pandemic (discussed in the company’s Form 10-Qs),
and what the company currently anticipates, based on what the company understands today, to be the impacts on the company for the remainder of the year and beyond. The company’s updated financial
guidance and outlook assume generally that the most significant adverse impacts from the pandemic on the company’s business, financial position, results of operations or cash flows occurred in the
second quarter of 2020. However, the company cannot predict how the pandemic will evolve or what impact it will continue to have, and there can be no assurance that the company’s underlying
assumptions are correct. As discussed more fully in the company’s Form 10-Qs (for Q1, Q2 and Q3), and among other factors, disruptions to the company’s operations (or those of its customers or supply
chain), additional costs, disruptions in the market, and impacts on programs or payments relating to the global COVID-19 pandemic, today and as it may evolve, can be expected to affect the company’s
ability to achieve guidance or meet expectations. In addition, the government budget, appropriations and procurement processes can impact our customers, programs and financial results. These
processes, including the timing of appropriations and the occurrence of an extended continuing resolution and/or prolonged government shutdown, as well as a breach of the debt ceiling, or changes in
support for our programs or in federal corporate tax rates, can impact the company's ability to achieve guidance or meet expectations.
(2) Non-GAAP metric. See Appendix.

-- 10 of 15 --

Appendix
11

-- 11 of 15 --

Non-GAAP Definitions
Non-GAAP Financial Measures Disclosure: This presentation contains non-GAAP (accounting principles generally
accepted in the United States of America) financial measures, as defined by SEC Regulation G and indicated by a
footnote in the text of the presentation. Definitions for the non-GAAP measures are provided below and reconciliations
are provided in the body of the presentation. Other companies may define these measures differently or may utilize
different non-GAAP measures.
MTM-adjusted diluted EPS: Diluted earnings per share excluding the per share impact of MTM (expense) benefit and
related tax impacts. This measure may be useful to investors and other users of our financial statements as a
supplemental measure in evaluating the company’s underlying financial performance per share by presenting the
company’s diluted earnings per share results before the non-operational impact of pension and OPB actuarial gains and
losses.
Segment operating income and segment operating margin rate: Segment operating income, as reconciled in the
“Non-GAAP Reconciliations – Segment Operating Income” table in the Appendix, and segment operating margin rate
(segment operating income divided by sales) reflect total earnings from our four segments, including allocated pension
expense we have recognized under CAS, and excluding unallocated corporate items and FAS pension expense. These
measures may be useful to investors and other users of our financial statements as supplemental measures in evaluating
the financial performance and operational trends of our sectors. These measures should not be considered in isolation or
as alternatives to operating results presented in accordance with GAAP.
Free cash flow: Net cash provided by operating activities less capital expenditures. We use free cash flow as a key
factor in our planning for, and consideration of, acquisitions, stock repurchases and the payment of dividends. This
measure may be useful to investors and other users of our financial statements as a supplemental measure of our cash
performance, but should not be considered in isolation, as a measure of residual cash flow available for discretionary
purposes, or as an alternative to operating cash flows presented in accordance with GAAP. Free cash flow is reconciled
in the “Non-GAAP Reconciliations – Free Cash Flow” table in the Appendix.
12

-- 12 of 15 --

Non-GAAP Reconciliations – Free Cash Flow (1)
13
(1)
(1)
Three Months
Ended September 30
▲%
Nine Months
Ended September 30
▲%
Q3
2019
Q3
2020
YTD
2019
YTD
2020
Net cash provided by
operating activities
$ 	1,139 	$ 	1,359 	19% 	$ 	1,833 	$ 	2,073 	47%
Less: capital expenditures 	(257) 	(287) 	12% 	(793) 	(828) 	4%
Free cash flow(1) 	$ 	882 	$ 	1,072 	22% 	$ 	1,040 	$ 	1,875 	80%
(1) Non-GAAP metric.

-- 13 of 15 --

Non-GAAP Reconciliations –
Segment Operating Income(1)
14
Three Months
Ended September 30
Millions 	Q3 2019 	Q3 2020
Sales 	$ 	8,475 	$ 	9,083
Segment operating income (1) 	955 	1,049
Segment operating margin % (1) 	11.3% 	11.5%
Reconciliation to operating income
Net FAS (Service)/CAS pension adjustment 	$ 	131 	$ 	108
Unallocated corporate expense:
Intangible asset amortization and PP&E step-up depreciation 	(98) 	(81)
Other unallocated corporate expense 	(37) 	(91)
Unallocated corporate expense: 	(135) 	(172)
Operating income 	$ 	951 	$ 	985
Operating margin % 	11.2% 	10.8%
(1) Non-GAAP metric.

-- 14 of 15 --

15

-- 15 of 15 --